These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25956075)

  • 81. A review of the development of Respimat Soft Mist Inhaler.
    Dalby R; Spallek M; Voshaar T
    Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Principles of metered-dose inhaler design.
    Newman SP
    Respir Care; 2005 Sep; 50(9):1177-90. PubMed ID: 16122401
    [TBL] [Abstract][Full Text] [Related]  

  • 83. InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator.
    Hira D; Okuda T; Mizutani A; Tomida N; Okamoto H
    J Pharm Sci; 2018 Jun; 107(6):1731-1735. PubMed ID: 29428382
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
    Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
    J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Use of Respimat Soft Mist inhaler in COPD patients.
    Anderson P
    Int J Chron Obstruct Pulmon Dis; 2006; 1(3):251-9. PubMed ID: 18046862
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Understanding pressurized metered dose inhaler performance.
    Ivey JW; Vehring R; Finlay WH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):901-16. PubMed ID: 25496601
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Albuterol Delivery via Facial and Tracheostomy Route in a Model of a Spontaneously Breathing Child.
    Cooper B; Berlinski A
    Respir Care; 2015 Dec; 60(12):1749-58. PubMed ID: 26286736
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Insights into Spray Development from Metered-Dose Inhalers Through Quantitative X-ray Radiography.
    Mason-Smith N; Duke DJ; Kastengren AL; Stewart PJ; Traini D; Young PM; Chen Y; Lewis DA; Soria J; Edgington-Mitchell D; Honnery D
    Pharm Res; 2016 May; 33(5):1249-58. PubMed ID: 26887680
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.
    Hindle M; Longest PW
    J Pharm Pharmacol; 2012 Sep; 64(9):1254-63. PubMed ID: 22881438
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluation of metered dose inhaler spray velocities using phase Doppler anemometry (PDA).
    Liu X; Doub WH; Guo C
    Int J Pharm; 2012 Feb; 423(2):235-9. PubMed ID: 22183132
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
    Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
    Fabbri LM; Kerwin EM; Spangenthal S; Ferguson GT; Rodriguez-Roisin R; Pearle J; Sethi S; Orevillo C; Darken P; St Rose E; Fischer T; Golden M; Dwivedi S; Reisner C
    Respir Res; 2016 Sep; 17(1):109. PubMed ID: 27586537
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In vitro characterization of the OptiChamber Diamond valved holding chamber.
    Hatley RH; von Hollen D; Sandell D; Slator L
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of patients' real-world post-dispensing use and storage environments of tiotropium bromide Respimat® soft mist inhaler on its in vitro dose delivery and lung deposition.
    Ammari WG; Khalil Mohammad M; Tayyem RF
    Pulm Pharmacol Ther; 2019 Oct; 58():101829. PubMed ID: 31352077
    [TBL] [Abstract][Full Text] [Related]  

  • 97. New analytical techniques to facilitate preformulation screening in propellant systems.
    Mogalian E; Kuehl PJ; Myrdal PB
    Int J Pharm; 2007 Aug; 340(1-2):223-9. PubMed ID: 17498897
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
    Abdou EM; Kandil SM; Morsi A; Sleem MW
    Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Factors affecting the stability and performance of ipratropium bromide; fenoterol hydrobromide pressurized-metered dose inhalers.
    Ninbovorl J; Sawatdee S; Srichana T
    AAPS PharmSciTech; 2013 Dec; 14(4):1294-302. PubMed ID: 23975571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.